Lupus Research Alliance Hails Approval of Aurinia’s Lupkynis(TM) (voclosoporin)
First Oral Treatment for Lupus Nephritis;
Second Lupus Treatment to Receive FDA Approval in Past Month
NEW YORK, NY. January...
National Kidney Foundation
New Survey Shows Education and Communication Gaps in Lupus Nephritis Care
1 in 2 Lupus Nephritis Patients Don’t Know They Have Lupus
New York, NY– December 7, 2020. Significant gaps in...
LRA Addressing Health Disparities Among Vulnerable Groups
February 20, 2020
The Lupus Research Alliance (LRA) works hard, often in concert with organizations like the National Minority Quality...
Lupus Research Alliance Applauds Phase III Trial Results for Potential Lupus Nephritis Treatment
December 4, 2019
The Lupus Research Alliance congratulates Aurinia Pharmaceuticals on achieving the first positive Phase III trial results for...
The Lupus Research Alliance Partners with the National Kidney Foundation to Offer Course to Healthcare Professionals
November 12, 2019
The Lupus Research Alliance (LRA) is pleased to announce a new collaboration with the National Kidney Foundation...